Cardio Care Live

CME Presentations

Heart Failure


Presentations

  • CME
    1.0

    Examining Guideline Recommendations for Patients with Heart Failure

    Speakers:Akshay S. Desai, MD, MPH, Director, Cardiomyopathy and Heart Failure Program
    James L. Januzzi, Jr., MD, FACC, FESC, Physician, Cardiology Division

    Duration: 60 minutes

    Presented on: December 6, 2017

  • CME
    1.0

    Expert-led Roundtable Discussion: Multidisciplinary Approaches to Implementing the Guidelines

    Speakers:Akshay S. Desai, MD, MPH, Director, Cardiomyopathy and Heart Failure Program
    James L. Januzzi, Jr., MD, FACC, FESC, Physician, Cardiology Division

    Duration: 60 minutes

    Presented on: February 9, 2018


Speakers

  • Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Akshay S. Desai, MD, MPH

    Director, Cardiomyopathy and Heart Failure Program

    Akshay Desai, MD, MPH, is the director of the Cardiomyopathy & Heart Failure Program in the Advanced Heart Disease Section of the Cardiovascular Division, Brigham and Women’s Hospital, and an associate professor of medicine at Harvard Medical School, both in Boston, Massachusetts. He divides his time between treating patients with advanced heart disease and clinical research in cardiovascular clinical trials, with emphasis on pathophysiology, pharmacologic treatment, and ambulatory management of patients with heart failure. He earned his MD from Harvard Medical School, completed an internal medicine internship and residency, as well as cardiovascular medicine and advanced heart failure fellowships, at Brigham and Women’s Hospital. He holds an MPH from the Harvard School of Public Health.
  • James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    James L. Januzzi, Jr., MD, FACC, FESC

    Physician, Cardiology Division

    James L. Januzzi, MD, is the Hutter Family Professor of Medicine at Harvard Medical School, a staff cardiologist at Massachusetts General Hospital, and senior cardiometabolic faculty at Baim Institute for Clinical Research in Boston. His research has contributed to the understanding of cardiac biomarker testing, where his studies have set international standards for use in diagnosis, prognosis, and management of patients suffering from acutely decompensated heart failure, chronic heart failure as well as those with acute coronary syndromes. Dr Januzzi has published hundreds of manuscripts, book chapters and review articles, has edited two textbooks on cardiac biomarker testing, and is on the editorial board of numerous scientific journals. He earned his MD from New York Medical College.

CME Information

Implementing Guideline-Directed Medical Therapy for Patients with Heart Failure


LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Describe recent recommendations detailed in the 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure
  • Utilize patient characteristics and comorbidities to direct treatment choice in accordance to guideline recommendations for patients with chronic HF
  • Compare and contrast the clinical trial safety and efficacy data for recently available agents
  • Individualize treatment choice, treatment initiation, and titration for recently available agents in the management of patients with chronic HF

Acknowledgement

This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.

Tuition

Complimentary

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements

Physician Continuing Education
Live Internet Activity

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Releasae/Expiration

Live Activity
Session I: Examining Guideline Recommendations for Patients with Heart Failure
Wednesday, December 6, 2017 from 10:00am – 11:00am EDT.

Session II: Expert-led Roundtable Discussion: Multidisciplinary Approaches to Implementing the Guidelines
Friday, February 9, 2018 from 10:00am – 11:00am EDT.

Enduring Material
Session I: The enduring material will be available from December 6, 2017 – August 9, 2018.
Session II: The enduring material will be available from February 9, 2018 – August 9, 2018.

Target Audience

This activity is intended for cardiologists, family medicine physicians, general internists, advanced practice providers and nurses, pharmacists, and hospitalists.

Estimated Time to Complete

This activity is intended for cardiologists, family medicine physicians, general internists, advanced practice providers and nurses, pharmacists, and hospitalists.

Method of Participation

There are no fees to participate in this activity. To participate in the activity, go to www.cardiocarelive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Hardware/Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Presenters

James L. Januzzi, Jr., MD, FACC, FESC Physician, Cardiology Division Director, Dennis and Marilyn Barry Fellowship in Cardiology Research Massachusetts General Hospital Hutter Family Professor of Medicine in the Field of Cardiology Harvard Medical School

Consulting Fees: Boehringer-Ingelheim, Novartis Contracted Research: Boehringer-Ingelheim, Novartis Endpoint Committee: Amgen, Boehringer-Ingelheim, Novartis

Akshay S. Desai, MD, MPH Director, Cardiomyopathy and Heart Failure Program Brigham and Women's Hospital Associate Professor of Medicine Harvard Medical School

Consulting Fees: Abbott, AstraZeneca, DalCor, Novartis, Relypsa Contracted Research: Novartis

John D. Goodson, MD Associate Professor of Medicine Harvard Medical School Physician Massachusetts General Hospital

None

Orly Vardeny, PharmD, MS Associate Professor of Pharmacy University of Minnesota Medical School

Consulting Fees: Novartis

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Financial Disclosures

Anne Roc Senior Medical Director PlatformQ Health Education, LLC

None

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Elizabeth del Nido, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unapproved/Off Label Use (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Discalimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com

Technical Support:
For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com